MATERIALS & METHODS BACKGROUND RESULTS OBJECTIVES SUMMARY

Slides:

Advertisements

Similar presentations

Intermediate stage HCC management

Advertisements

Radiotherapeutic Option in Management of Hepatocellular Carcinoma

High Intensity Focused Ultrasound (HIFU) for Liver Tumour Dr Dai Wing Chiu Queen Mary Hospital.

High-Intensity Focused Ultrasound for Hepatocellular Carcinoma Joint Hospital Surgical Grand Round Queen Mary Hospital 19/10/2013.

Interventional Oncology Michael Kotton MD October 27, 2012.

18F- FDG PET/CT in the Diagnosis of Tumor Thrombosis

Post oral surgery bleeding for adult patients receiving antithrombotic therapy.

Venous Thromboembolism Prevention August Venous Thromboembloism Prevention 2 Expected Practice  Assess all patients upon admission to the ICU for.

Venous Thromboembolism (VTE) Prophylaxis Policy Mary-Anne Davies Patient Safety Specialist Accreditation Coordinator.

Venous Thromboembolism

Hepatocellular Carcinoma Detection and Treatment

Anticoagulant therapy in RPL Dr. Z. Heidar Assistant professor SBMU.

Colorectal Cancer Center Jena Introduction In Germany, there are currently approximately newly diagnosed patients with colorectal carcinoma.

Diagnosis of HCC History & PE Serologic Assays Radiology

Bridging Oral Anticoagulation with Low Molecular Weight Heparin: Experience in 367 Patients with Renal Insufficiency Heyder Omran, Giso von der Recke,

IMPLEMENTING GUIDELINES AND REDUCING PATIENT RISK OF VENOUS THROMBOEMBOLISM IN A LARGE UK TEACHING HOSPITAL Sharron Millen, Head of Clinical Pharmacy and.

The Role of Thromboprophylaxis in Elective Spinal Surgery The Role of Thromboprophylaxis in Elective Spinal Surgery VA Elwell, N Koo Ng, D Horner & D Peterson.

Low-molecular-weight heparin (LMWH) use in an oncological setting Emma Lowe, Melanie Lowe, Hilary Oldham, Joan Karasu. Clinical service technicians, Pharmacy.

Mandatory Training: VTE prevention and anticoagulation practice Mandatory Training: VTE prevention and anticoagulation practice Mr A McSorley Lead Thrombosis.

CESAR SOTO PGY -2 STONY BROOK UNIVERSITY HOSPITAL Non-traumatic abdominal pain CT imaging review.

HCC Guidelines and recommendation Diagnostic algorithm and recall policy.*One imaging technique only recommended in centers of excellence with high-end.

One of the main causes of DVT is inactivity! When a person is inactive, your blood normally collects in the lower part of your body. (in your legs) This.

CLINICAL OUTCOME OF 251 PATIENTS WITH EXTRAHEPATIC METASTASIS AT INITIAL DIAGNOSIS OF HEPATOCELLULAR CARCINOMA: DOES TRANSARTERIAL CHEMOEMBOLIZATION IMPROVE.

Conclusions Results Methods Background Venous thrombo-embolism in patients undergoing neo- adjuvant chemotherapy and surgery for oesophago-gastric cancer.

Impact of Anticoagulation Regimens on Sheath Management and Bleeding in Patients Undergoing Elective Percutaneous Coronary Intervention in the STEEPLE.

Fotlos Laspas'. Evangelia Sotiropoitlou'. Sophia Myhna^. Anita Manataki', Paraskevi TsagouW. Iris Tsangaridou', Loukas Thanos'

Introduction; font size

Dr. Mohammed Omar Khalifa

Hepatocellular Carcinoma: Diagnosis and Management

Venous Thromboembolism Prophylaxis (VTE)

The efficacy and safety of oral Rivaroxaban in patients with permanent inferior vena cava filter: a pilot case-control study Lobastov K., Barinov V.,

P0866 Combination of Low dose Thiopurine and Allopurinol in patients with ulcerative colitis Please export the Keynote document as a PDF (File – Save as.

TACE of Metastatic HCC to the Pleura

RADIOLOGICAL AND HISTOPATHOLOGICAL CHARACTERISTIC FEATURES OF BREAST CANCER PATIENTS IN HOSPITAL SERDANG Lim SN.1, Nuratika B.1, Suraini M.S.2, Norafida.

The ART of Decision Making : Retreatment with Transarterial Chemoembolization in Patients with Hepatocellular Carcinoma Wolfgang Sieghart, Florian Hucke,

Fig. 4. First-line treatment according to 2014 KLCSG-NCC Korea Practice Guidelines for patients with HCC, Child-Pugh class A, no portal hypertension, and.

Mansoura University, Mansoura, Egypt

Comparing Accuracy of Ultrasound to Chest X-ray in Determining Pulmonary Edema Matt Wooten, DO PGY 2 5/4/2017.

APEX Trial design: Patients hospitalized with an acute medical illness were randomized to oral betrixaban for days (n = 3,759) versus subcutaneous.

Fig. 2. Comparative efficacy of thromboprophylaxis interventions in the prevention of deep vein thrombosis (DVT). (A) Estimated odds ratios (ORs) and 95%

Facilitator: pawin puapornpong

Dr.H.Chandrashekar, Dr.A.Chaudhuri, Dr. A. Douglas, Dr. D. Lowdon

Surgical Treatment of Different Types of Pancreatic Cancers- Clinical Center of Serbia Experiances Vladimir Djordjevic, Nemanja Zaric, Zeljko Radojkovic,

CRE prevalence among patients with no prior history of carriage

Copyright © 2012 American Medical Association. All rights reserved.

Full-Spectrum Endoscopy Improves Adenoma Detection Compared to Conventional Colonoscopy PLUS Right-Colon Examination With Scope Retroflexion: A Randomized,

Introduction; font size

Presented By: Sally Saad Mandour Esawy

Introduction; font size 12

Paul D. Stein, MD, Russell D. Hull, MBBS, MSc, Fadi Matta, MD, Abdo Y

Evidence Based Practice Poster Title Author(s) Name(s), Degree, License, Certification, Institution and/or Department Affiliations Purpose Methods Results.

Caprini venous thromboembolism risk assessment permits selection for postdischarge prophylactic anticoagulation in patients with resectable lung cancer

Don't look now! Risk stratify first

Succinct Review of the New VTE Prevention and Management Guidelines

Chen S, Dong Y, Kiuchi MG, et al

How I treat cancer-associated venous thromboembolism

Introduction. Emerging Treatments for Thrombocytopenia in Adults With CLD Requiring Elective Invasive Procedures.

Treatment and secondary prevention strategy diagram for VTE in patients with active cancer based on the treatment guidelines for cancer-associated VTE.

Incidence of (A) recurrent VTE and (B) major bleeding in select randomised clinical trials of LMWH for the treatment and secondary prevention of VTE in.

Introduction; font size 12

Introduction; font size 12

Thrombophilia in pregnancy: Whom to screen, when to treat

Assessed for eligibility

Combined locoregional-immunotherapy for liver cancer

Microvascular Invasion as a Predictor of Response to Treatment with Sorafenib and Transarterial Chemoembolization for Recurrent Intermediate-Stage Hepatocellular.

Introduction; font size 12

Imaging findings and complications of transcatheter interventional treatments via the inferior phrenic arteries in patients with hepatocellular carcinoma

Model for end‐stage liver disease exception points for treatment‐responsive hepatocellular carcinoma Treatment‐responsive HCC: patient with complete response.

Multidisciplinary team approach to hepatocellular carcinoma management in a liver transplant center from Romania Cerban R.1, Iacob S.1, Croitoru A.1, Popescu.

Picture with at least 1500x1500 pixels size

Presentation transcript:

MATERIALS & METHODS BACKGROUND RESULTS OBJECTIVES SUMMARY Table (4):- Incidence of portal vein thrombosis. Role of Low Molecular Weight Heparins (LMWH) in Prevention of Thromboembolic Complication After Transarterial Chemoembolization (TACE) in Hepatocellular Carcinoma. Osama Negm 1, Sabry Abou Saif 1, Mohamed El Gharib 2, Mohamed Yousef 1, Sherief Abd-Elsalam 1. MATERIALS & METHODS BACKGROUND RESULTS Please export the Keynote document as a PDF (File – Save as – PDF – Image Quality – Best) and upload the PDF into the system. Please use the font in the document or a similar one and do not use a font size smaller than 16. This study was conducted on 40 patients with HCC requiring Transarterial chemoembolization who presented to the Tropical Medicine Department Tanta University and Interventional Radiology. The incidence of portal vein thrombosis after TACE was more in group I than group II with Seven cases in group I & only one case in group II. Portal vein thrombosis is a common complication after Transarterial Chemoembolization (TACE) in Hepatocellular Carcinoma (HCC). This study was conducted on 40 patients with HCC requiring Transarterial chemoembolization who presented to the Tropical Medicine Department Tanta University and Interventional Radiology Department of Ain Shams University Hospitals starting from April 2015. OBJECTIVES PVT Group Group I Group II Total N % Negative 13 65.00 19 95.00 32 85.00 Positive 7 35.00 1 5.00 8 15.00 Chi- squar e X2 3.906 P- value 0.048 Patients were divided in two groups: Group I: included 20 patients with HCC treated by TACE only. Group II: included 20 patients with HCC treated by TACE and adjuvant dose of LMWH. Radiological Assessment of efficacy of procedure and detection of portal vein thrombosis as a complication was done using ultrasound abdomen and pelvis and triphasic spiral C T with contrast. This is the first clinical study to evaluate the role of low molecular weight heparins (LMWH) with TACE in HCC for prevention of thromboembolism complications (portal vein thrombosis). SUMMARY LMWH with TACE in hepatocellular carcinoma is strongly recommended for prevention of thromboembolism complications (portal vein thrombosis). However, larger randomized controlled studies are needed to confirm these obvious findings. Table (1):- Incidence of portal vein thrombosis. Contact information: www.Sheriefabdelsalam.com LMWH with TACE in hepatocellular carcinoma is strongly recommended for prevention of thromboembolism complications (portal vein thrombosis). However, larger randomized controlled studies are needed to confirm these obvious findings.